On September 19, 2022 Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, reported that the 2nd Annual VISTA Symposium will take place virtually on September 23, 9:00am-1:00pm ET (Press release, Curis, SEP 19, 2022, View Source [SID1234619671]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
The event will be hosted by Randolph Noelle, Ph.D., Active Emeritus Professor of Microbiology and Immunology, Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth. Global leaders in immuno-oncology will gather at the Symposium to discuss the VISTA checkpoint, its role in cancer, and the latest VISTA research and therapeutic development.
"Curis is pleased to continue its sponsorship of the Annual VISTA Symposium," said James Dentzer, President and Chief Executive Officer of Curis. "As the global leader in VISTA development, we are honored to provide a forum for discussing the progress we’re seeing with CI-8993, our own VISTA program, as well as programs from other companies and academic labs, as we collectively advance the forefront of VISTA research and development for the benefit of patients living with cancer."
The virtual event features agenda topics including:
VISTA Biology
Biology Overview
VISTA ligands and counterreceptors
Role of VISTA in Tumor Immune Evasion
VISTA Targeting
The PK/PD complexities of target mediated disposition
PET Imaging of VISTA targeting
Clinical Opportunities and Questions
Biomarkers, pathways and tumor subsets
Anti-VISTA antibody in combination with radiation therapy
Translational immunology in cutaneous malignancies
Anti-VISTA Therapeutic Strategies
To learn more about the symposium and register to attend, please visit https://bit.ly/VISTA22.